University Health Network, Toronto: Infections trials
The registry lists 11 Infections studies with University Health Network, Toronto as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 4Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- M. Avium WGS During Mav-PD TreatmentRecruitingNCT06266442
- Antimicrobial Resistant Organism Decolonization After Microbiome PerturbationWithdrawnNCT06214403Phase 2
- Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19)Status unknownNCT05085262
- Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and SeverityCompletedNCT04439045Phase 3
- Survey of the Facial BacteriomeCompletedNCT04180748
- Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral VancomycinTerminatedNCT01226992Phase 2/3
- Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?CompletedNCT00860977Phase 3
- FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral TherapyCompletedNCT00606528
- Use of Ointments in Prevention of Catheter Related Infections in PDCompletedNCT00400595Phase 4
- Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral MedicationTerminatedNCT00296972Phase 3
- Screening for HIV-Associated Anal CancerCompletedNCT00188292